Clinical Trials Sponsored by Hanna Jangö

Total 257 results

Hanna Jangö

Completed

Translation and Validation of the ICIQ-B in Danish

Quality of Life | Pelvic Floor Disorders | Anal Incontinence | Anal Sphincter Tear

Denmark
Hanna Jangö
Region Hovedstadens Apotek

Recruiting

Oral Antibiotics After Obstetric Perineal Tear (REPAIR)

Infections | Wound Dehiscence | Obstetric Trauma

Denmark
Nasser Hanna

Completed

Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse

Neoplasms, Germ Cell and Embryonal

United States
Nasser Hanna

Completed

Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Testis Cancer | Testicular Cancer | Germ Cell Tumor

United States
Hanna van Eijsden

Not yet recruiting

Vibrotactile Feedback Belt in Patients With Unilateral Vestibular Hypofunction (UVH) (VIBE)

Vestibular Disorder

Netherlands
Hanna Holmberg
University of Salford

Completed

Isometric Core Muscle Endurance in Healthy Active and Non-active Working Age Populations

Physical Endurance

United Kingdom
Hansa Biopharma AB

Recruiting

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children (DINKY)

Kidney Transplantation in Highly Sensitized Patients

Spain, Finland, Sweden
Hansa Biopharma AB

Recruiting

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys (ConfIdeSLTFU)

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Recruiting

A Study With Imlifidase in Anti-GBM Disease (GOOD-IDES-02)

Anti-Glomerular Basement Membrane Disease | Goodpasture Syndrome | Anti-Glomerular Basement Membrane Antibody Disease | Good Pasture Syndrome

United States, Netherlands, Spain, Sweden, United Kingdom, Czechia, Germany, Italy, France, Denmark
Hansa Biopharma AB

Recruiting

Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Completed

Safety Study on IdeS in Healthy Volounteers

Healthy

Sweden
Hansa Biopharma AB

Completed

A Study of Imlifidase in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome (GBS)

France, Netherlands, United Kingdom
Hansa Biopharma AB

Completed

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Kidney Transplant Failure and Rejection

United States, Sweden, France
Hansa Biopharma AB

Completed

Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease

Chronic Kidney Disease

Sweden
Hansa Biopharma AB

Recruiting

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group (PAES-LTFU)

Long Term Efficacy and Safety

Spain, Czechia
Hansa Biopharma AB

Recruiting

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts (PAES)

Kidney Transplantation in Highly Sensitized Patients

Germany, Spain, Italy, France, Netherlands, Belgium, Austria, Czechia, Sweden, United Kingdom, Slovenia
Hansa Biopharma AB

Completed

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Kidney Transplant Rejection

Australia, United States, Germany, France, Austria
Hansa Biopharma AB

Active, not recruiting

A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Terminated

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Kidney Transplant Rejection

Germany, France, Austria
Hansa Biopharma AB

Completed

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test (Highdes)

Kidney Failure, Chronic

United States, Sweden, France
David Jang, M.D.
Amgen

Completed

Erenumab for Idiosyncratic Facial Pain

Facial Pain | Rhinosinusitis

United States
St. Anna Kinderkrebsforschung

Recruiting

High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

Neuroblastoma

Norway, Czechia, United Kingdom, France, Spain, Belgium, Switzerland, Hungary, Israel, Australia, Italy, Austria, Denmark, Greece, Ireland, Poland, Portugal, Slovakia, Slovenia, Sweden
St. Anna Kinderkrebsforschung

Completed

Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections (FUNGITECT)

Systemic Mycosis

Austria, Netherlands, Russian Federation
St. Anna Kinderkrebsforschung

Withdrawn

Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation (VISIT)

Cytomegalovirus Infection | Adenovirus Infection

Austria
S. Anna Hospital

Unknown

Ultrasound Evaluation of the Jugular Venous Pulse (US-JVP) (US-JVP)

Cardiovascular Diseases | Emergencies | Neurovascular Disorders

Italy
Sylvia Maher Mohsen Farid Hanna

Not yet recruiting

The Effect of Manual Lymphatic Drainage on Acute and Post-acute Ankle Sprain in Athletes

Ankle Sprains
St. Anna Kinderkrebsforschung

Completed

COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS) (INPOSIS)

Covid19 | SARS-CoV-2 Infection | Intestinal Infection

Austria
S. Anna Hospital

Unknown

Tap Block and Cesarean Delivery: Efficacy and Consumption of Postoperative Drugs (TAPFANS)

Cesarean Delivery

Italy
S. Anna Hospital

Completed

Safety of High-dose Tirofiban During Coronary Angioplasty (SANTISS)

Coronary Artery Disease

Italy
Hannah Antony

Not yet recruiting

Home-based Treatment Using the Sidekick Tool for Pain Relief in Patients With Iliotibial Band Syndrome

Iliotibial Band Syndrome
St. Anna Kinderkrebsforschung

Completed

Allogeneic Stem Cell Transplantation for Children With CML

Chronic Myeloid Leukemia

Austria, Czechia, Italy
St. Anna Kinderkrebsforschung

Unknown

ALL-SCT BFM International- HSCT in Children and Adolescents With ALL (ALL-SCT-BFMi)

Lymphoblastic Leukemia, Acute, Childhood;

Israel, Austria, Czech Republic, Denmark, France, Italy, Netherlands, Poland, Slovakia, Sweden, Turkey
hanaa mohsen

Completed

Effect of Platform Swing Walkway on Locomotor Behavior in Diplegic Children

Vestibular Rehabilitation

Egypt
Hanan Nabil

Completed

Preemptive Analgesia for Primary Dysmenorrhoea

Primary Dysmenorrhea

Egypt
hanaa mohsen

Completed

Effect of Core Stability Exercises on Hand Functions in Children With Hemiparesis

Cerebral Palsy

Egypt
Hanna Kahila
Helsinki University Central Hospital; Lastentautien tutkimussäätiö

Not yet recruiting

Alcohol Use During Pregnancy in Finland According to Meconium Samples (RASMEK21)

Fetal Alcohol Spectrum Disorders
Hanan Jafar

Recruiting

Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Knee Osteoarthrosis

Jordan
Hanan Jafar

Recruiting

Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Knee Osteoarthrosis

Jordan
hanan fawzy

Active, not recruiting

Acute Toxicity After Moderate Hypo-fractionated Intensity Modulated Radiotherapy IMRT or Prostate Cancer

Radiation Toxicity

Egypt
Hanan Jafar

Unknown

Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot Ulcers

Diabetic Foot Ulcer
Ibn Sina Hospital
Ganna Hospital

Completed

Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium (PRPITM)

Poor Endometrium

Egypt
Anna Martling

Active, not recruiting

Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study (CITCCA)

Colorectal Cancer

Sweden, Norway
Anna Sprinchorn

Active, not recruiting

Effects on Patient Satisfaction and Gait After Loss of Peroneus Longus Function

Patient Satisfaction | Gait, Rigid

Sweden
St. Anna Clinic Luzern

Completed

Lumbar Spine Surgery: Regional vs. General Anaesthesia

Herniated Disk Lumbar

Switzerland
Anna Aronsson
Uppsala University

Completed

Long-term Mortality After Intensive Care Considering Comorbidity and Admission Diagnoses

Critical Care

Sweden
Ibn Sina Hospital
Ganna Hospital

Completed

High Versus Free Humidity Incubators; A Randomized Clinical Trial

Ongoing Pregnancy Rate

Egypt
Hanan Jafar

Completed

Autologous Platelet Lysate in Corneal Epithelial Defects

Persistent Corneal Epithelial Defect

Jordan
Hanan Jafar

Unknown

The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer

Diabetic Foot Ulcer

Jordan
Nasser Hanna
Genentech, Inc.

Recruiting

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

NSCLC | Lung Cancer

United States
Nasser Hanna
Genentech, Inc.

Terminated

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

NSCLC Stage IV | NSCLC, Recurrent

United States

Clinical Trials Sponsored by Hanna Jangö

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations